//Blood Safety and Emerging Transmission Diseases: Future Trends and Innovations
It has always been important to identify new virus outbreaks and emerging diseases, such as Dengue, Zika, and Chikungunya, and it is becoming increasingly crucial to maintain vigilance and adapt testing protocols to ensure blood safety. The eclatant longevity and influence of these viral threats confirm how stop-and-go nature of these diseases exacerbates their unpredictable spread. It is vital to strategically establish robust screening protocols to quickly adapt to and mitigate these risks.
## The Evolving Landscape of Dengue, Zika, and Chikungunya
### Increasing Frequency and Complexity
From 2000 to 2010, China observed localized outbreaks of Chikungunya fever in Guangdong, with subsequent outbreaks in Zhejiang and Yunnan in 2017 and 2019, respectively. Each outbreak lasted longer and showed a higher proportion of imported cases, highlighting the growing risk of international transmission. Since 2016, sporadic Zika virus cases have also been documented, primarily imported. Dengue fever in Yunnan Province exhibited a biennial pattern between 2010 and 2021, with frequent imported cases and a notable increase in local transmission. Asymptomatic Dengue infections present a critical challenge, with over 75% of infections showing no symptoms, posing a significant risk to blood transfusion safety.
## The Role of NAT in Diagnosing and Screening
### Accurate and Early Detection
RNA detection via nucleic acid testing (NAT) is pivotal in early infection diagnosis, making it the primary tool for accurate arbovirus identification. Targeted testing in regions experiencing regular seasonal outbreaks, as recommended by the Asia Pacific Blood Network (APBN), helps in early detection and prevention.
### Implementation in China
The National Health Commission of the People’s Republic of China (NHC) initiated NAT screening for Dengue, Zika, and Chikungunya viruses at eight central blood stations in Yunnan and Guangxi in 2022. This initiative aims to enhance screening capabilities and ensure rapid epidemiological response. Quality control materials, developed by the National Center for Clinical Laboratories (NCCL), have been instrumental in evaluating all domestic blood screening reagents and conducting external quality assessments (EQA).
### Ensuring Quality and Accuracy
Pseudoviruses, prepared using Moloney Murine Leukemia Virus (MMLV), have been crucial in evaluating reagent performance and conducting EQA. Digital PCR was used to quantify pseudoviruses, ensuring precise limit of detection (LoD) and precision evaluations.
## Current Screening Initiatives and Outcomes
### Extensive Screening Efforts
Blood screening for Dengue, Zika, and Chikungunya viruses was conducted at eight border central blood stations across 11 cities in Guangxi and Yunnan from June to August 2022 and 2023. The reagents used were from either Manufacturer A or Manufacturer E, ensuring diverse and reliable screening methods.
## Key Insights from Screening Data
### 2023 Screening Results
In 2023, among 44,972 samples screened, 9 Dengue-reactive samples (designated 2301–2309) were identified at the Xishuangbanna central blood station using reagent A. Six of these samples were subsequently confirmed as Dengue-positive, all positive for DENV type 1. Successful sequencing of several samples revealed a close phylogenetic relationship with strains from Southeast Asian countries, suggesting importation from the region. Testing of reactive samples was done using NAT reagents, serological tests for IgG/IgM, and Non-structural protein 1 (NS1) antigen. Follow-up testing confirmed prior Dengue infection, highlighting the virus’s prolonged infectivity.
## Future Trends and Innovations
### Advanced Screening Techniques
Future trends in combustion analysis will likely focus on more sophisticated screening techniques. NAT technology will continue to evolve, offering quicker and more accurate results and doing so using advanced equipment.
### Heightened Surveillance and Preparedness
The continuous evolution of NAT reagents will improve the reliability and sensitivity of blood screening. Increased surveillance and preparedness for emerging diseases will be crucial in ensuring blood safety. The establishment of national and international collaborations will enhance the rapid response to outbreaks and the development of standard protocols.
In Pakistan, ongoing disease surveillance involves collecting epidemiological data on Cholera, Dengue, and other significant diseases. Strategies are evolving to enhance their readiness to meet outbreaks of Dengue and Cholera, including training and capacity building among healthcare staff.
## Fostering International Collaboration
International collaboration is key to sharing best practices, data, and advancements in testing technologies. These efforts will help in developing comprehensive screening protocols to combat emerging viruses and ensure global blood safety.
## Easy-to-Use Guidelines for Enhancing Safety
The World Health Organization (WHO) and other health organizations provide guidelines for enhancing safety in blood transfusion services. These guidelines emphasize the need for continuous monitoring, rigorous standardization, and the implementation of advanced screening techniques.
## Frequently Asked Questions
**Q: What are the main factors contributing to the rise in Dengue, Zika, and Chikungunya outbreaks?**
A: The increasing frequency of outbreaks is largely due to globalization, climate change, and the growing proportion of asymptomatic cases, which complicates detection and control.
**Q: How does NAT improve blood safety?**
A: NAT provides early and accurate detection of viral infections, which is crucial for identifying potential donors who may be carrying transmissible viruses.
**Q: What role do quality control materials play in blood screening?**
A: Quality control materials ensure the reliability and accuracy of screening reagents, helping to maintain high standards in blood safety.
## Did you know?
National and internationational studies point to the rising temperatures and shifting climatic patterns as being huge factors in the nuances of these diseases.
## ‘Pro Tip’ Box
Consider incorporating social determinants and coping mechanisms in disease surveillance and outbreak response strategies. Understanding these factors can help tailor interventions to specific contexts and populations.
A: Understanding these factors can help tailor interventions to specific contexts and populations, thereby maximizing the effectiveness of outbreak response strategies. Engaging local communities and healthcare workers in data collection and intervention implementation can also enhance the successfulness of outbreak control measures.
